+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemotherapy Agent"

Carcinoid Syndrome - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Carcinoid Syndrome - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • November 2025
  • 200 Pages
  • Global
From
Oropharyngeal Cancer - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Oropharyngeal Cancer - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • November 2025
  • 200 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • November 2025
  • 200 Pages
  • Global
From
Adenoid Cystic Carcinoma - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Adenoid Cystic Carcinoma - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • November 2025
  • 200 Pages
  • Global
From
CAR T-Cell Therapy for Multiple Myeloma - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

CAR T-Cell Therapy for Multiple Myeloma - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • November 2025
  • 200 Pages
  • Global
From
Retifanlimab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Retifanlimab Sales Forecast and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Minimal Residual Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Peritoneal Cancer - Pipeline Insight, 2026 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 280 Pages
  • Global
From
Checkpoint Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Antibody-drug Conjugates (ADCs) in Oncology - Competitive Landscape, 2026 - Product Thumbnail Image

Antibody-drug Conjugates (ADCs) in Oncology - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
CAR T - Cell Therapy - Competitive Landscape, 2026 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive Landscape, 2026

  • Report
  • January 2026
  • 500 Pages
  • Global
From
Chemotherapy-Induced Neutropenia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Chemotherapy-Induced Neutropenia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 143 Pages
  • Global
From
Kaposi Sarcoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Kaposi Sarcoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 120 Pages
  • Global
From
Vulvar Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Vulvar Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 140 Pages
  • Global
From
Hepatic Tumor Pipeline Analysis Report 2025 - Product Thumbnail Image

Hepatic Tumor Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035) - Product Thumbnail Image

Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • May 2026
  • 350 Pages
  • Global
From
Metastatic Urothelial Carcinoma Pipeline Analysis Report 2026 - Product Thumbnail Image

Metastatic Urothelial Carcinoma Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Cancer Supportive Care Drugs Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Thumbnail Image

Cancer Supportive Care Drugs Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • May 2026
  • 350 Pages
  • Global
From
HER2 Positive Gastric Cancer Pipeline Analysis Report 2026 - Product Thumbnail Image

HER2 Positive Gastric Cancer Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Liver Cancer Therapeutics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Thumbnail Image

Liver Cancer Therapeutics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • May 2026
  • 350 Pages
  • Global
From
Loading Indicator

The Chemotherapy Agent market within the Healthcare Services sector is a rapidly growing industry. It is composed of a variety of products and services that are used to treat cancer and other diseases. These products and services include drugs, medical devices, and other treatments. The market is driven by the increasing prevalence of cancer and other diseases, as well as the development of new treatments and technologies. The Chemotherapy Agent market is highly competitive, with many companies offering a wide range of products and services. Companies in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Roche. These companies are constantly innovating and developing new products and services to meet the needs of patients and healthcare providers. Show Less Read more